Literature DB >> 18503560

Antiepileptogenic and antiictogenic effects of retigabine under conditions of rapid kindling: an ontogenic study.

Andréy Mazarati1, Jim Wu, Don Shin, Young Se Kwon, Raman Sankar.   

Abstract

PURPOSE: To examine antiepileptogenic and antiictogenic potential of retigabine (RTG) under conditions of rapid kindling epileptogenesis during different stages of development.
METHODS: The experiments were performed in postnatal day 14 (P14), P21, and P35 male Wistar rats. After stereotaxic implantation of hippocampal stimulating and recording electrodes, the effects of RTG on baseline afterdischarge (AD) properties were studied. Next, the animals underwent rapid kindling (sixty 10 s trains, bipolar 20 Hz square wave pulses delivered every 5 min). The progression of seizures (kindling acquisition), and responses to test stimulations after kindling (retention) were compared between RTG and vehicle-treated rats. Additionally, the effects of RTG on the severity of seizures in previously kindled animals were examined.
RESULTS: When administered intraperitoneally in doses that induced only mild, or no motor deficits, RTG significantly dampened brain excitability, evident as the increase of AD threshold and shortening of AD duration. During kindling, RTG delayed the development of focal seizures in P14 rats, and prevented the occurrence of full limbic seizures at all three ages. At P14 and P21, but not at P35, pretreatment with RTG prevented the establishment of kindling-induced enhanced seizure susceptibility. Administration of RTG to kindled animals decreased the severity of seizures induced by test stimulation. The effect was most prominent at P14. DISCUSSION: RTG exerted both antiepileptogenic and antiictogenic effects under conditions of rapid kindling model. These effects were apparent during postneonatal, early childhood, and adolescent stages of development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18503560      PMCID: PMC2577127          DOI: 10.1111/j.1528-1167.2008.01674.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  47 in total

1.  Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop.

Authors:  James P Stables; Ed Bertram; F E Dudek; Greg Holmes; Gary Mathern; Asla Pitkanen; H S White
Journal:  Epilepsia       Date:  2003-12       Impact factor: 5.864

2.  Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release.

Authors:  K Vervaeke; N Gu; C Agdestein; H Hu; J F Storm
Journal:  J Physiol       Date:  2006-07-13       Impact factor: 5.182

3.  Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by low magnesium in rat entorhinal cortex hippocampal slices.

Authors:  V Armand; C Rundfeldt; U Heinemann
Journal:  Epilepsia       Date:  2000-01       Impact factor: 5.864

4.  A neurochemical study of the novel antiepileptic drug retigabine in mouse brain.

Authors:  G J Sills; C Rundfeldt; E Butler; G Forrest; G G Thompson; M J Brodie
Journal:  Pharmacol Res       Date:  2000-12       Impact factor: 7.658

5.  Rapid kindling in preclinical anti-epileptic drug development: the effect of levetiracetam.

Authors:  Tim De Smedt; Kristl Vonck; Robrecht Raedt; Stefanie Dedeurwaerdere; Pieter Claeys; Benjamin Legros; Tine Wyckhuys; Wytse Wadman; Paul Boon
Journal:  Epilepsy Res       Date:  2005-11-09       Impact factor: 3.045

6.  Kindling with rapidly recurring hippocampal seizures.

Authors:  E W Lothman; J M Hatlelid; C F Zorumski; J A Conry; P F Moon; J B Perlin
Journal:  Brain Res       Date:  1985-12-23       Impact factor: 3.252

7.  The effects of D-23129, a new experimental anticonvulsant drug, on neurotransmitter amino acids in the rat hippocampus in vitro.

Authors:  I M Kapetanovic; W D Yonekawa; H J Kupferberg
Journal:  Epilepsy Res       Date:  1995-11       Impact factor: 3.045

8.  Effects of age and sex on the disposition of retigabine.

Authors:  Robert Hermann; Geraldine M Ferron; Katharina Erb; Norbert Knebel; Peter Ruus; Jeffrey Paul; Lyette Richards; Hans-Peter Cnota; Steven Troy
Journal:  Clin Pharmacol Ther       Date:  2003-01       Impact factor: 6.875

9.  Rapid kindling in the prepubescent rat.

Authors:  G L Holmes; J L Thompson
Journal:  Brain Res       Date:  1987-12-01       Impact factor: 3.252

10.  D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures.

Authors:  A Rostock; C Tober; C Rundfeldt; R Bartsch; J Engel; E E Polymeropoulos; B Kutscher; W Löscher; D Hönack; H S White; H H Wolf
Journal:  Epilepsy Res       Date:  1996-04       Impact factor: 3.045

View more
  19 in total

1.  Activation of KCNQ Channels Suppresses Spontaneous Activity in Dorsal Root Ganglion Neurons and Reduces Chronic Pain after Spinal Cord Injury.

Authors:  Zizhen Wu; Lin Li; Fuhua Xie; Junhui Du; Yan Zuo; Jeffrey A Frost; Susan M Carlton; Edgar T Walters; Qing Yang
Journal:  J Neurotrauma       Date:  2017-02-27       Impact factor: 5.269

Review 2.  Novel medications for epilepsy.

Authors:  Cinzia Fattore; Emilio Perucca
Journal:  Drugs       Date:  2011-11-12       Impact factor: 9.546

3.  Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling.

Authors:  Raman Sankar; Stéphane Auvin; Young Se Kwon; Eduardo Pineda; Don Shin; Andréy Mazarati
Journal:  Epilepsia       Date:  2010-07       Impact factor: 5.864

4.  Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA.

Authors:  Stéphane Auvin; Don Shin; Andrey Mazarati; Raman Sankar
Journal:  Epilepsia       Date:  2010-07       Impact factor: 5.864

5.  Profile of retigabine-induced neuronal apoptosis in the developing rat brain.

Authors:  Lindsay Brown; Samuel Gutherz; Catherine Kulick; Colin Soper; Alexei Kondratyev; Patrick A Forcelli
Journal:  Epilepsia       Date:  2016-02-10       Impact factor: 5.864

Review 6.  Novel animal models of pediatric epilepsy.

Authors:  Stéphane Auvin; Eduardo Pineda; Don Shin; Pierre Gressens; Andrey Mazarati
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

7.  Inflammation enhances epileptogenesis in the developing rat brain.

Authors:  Stéphane Auvin; Andrey Mazarati; Don Shin; Raman Sankar
Journal:  Neurobiol Dis       Date:  2010-06-19       Impact factor: 5.996

8.  Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats.

Authors:  Ajay K Srivastava; H Steve White
Journal:  Epilepsy Res       Date:  2012-11-14       Impact factor: 3.045

9.  Bumetanide inhibits rapid kindling in neonatal rats.

Authors:  Andréy Mazarati; Don Shin; Raman Sankar
Journal:  Epilepsia       Date:  2009-02-26       Impact factor: 5.864

10.  Before epilepsy unfolds: opening up the potassium door in neonatal seizures.

Authors:  Rod C Scott; Gregory L Holmes
Journal:  Nat Med       Date:  2012-11       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.